Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Health Canada · 2 medicines
CBG-MEB · 1 medicine
TFDA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
5 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Nalbuphine | United States | 10MG/ML, 20MG/ML | Injectable | Not marketed | Quad Pharms |
| Nalbuphine | United States | 10MG/ML, 200MG/10ML, 20MG/ML | solution | Not marketed | Abraxis Pharm |
| Nalbuphine Hydrochloride | United States | 100MG/10ML, 10MG/ML, 200MG/10ML … | solution | Marketed | Igi Labs INC |
| Nalbuphine Hydrochloride | United States | 1.5MG/ML | injectable | Not marketed | Abbvie |
| Nubain | United States | 100MG/10ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 10MG/ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 200MG/10ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effect | solution | Not marketed | PH Health |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of Anvisa, CBG-MEB, FDA, Health Canada and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
